Rotavirus is the single most important cause of severe diarrhea in humans and is diffuse in most animal species worldwide, and an understanding of the antigenic properties of the virus is essential to the design of rational vaccine strategies. To better understand the localization of viral epitopes involved in antibody-mediated neutralization of virus infectivity, we have orally immunized mice with live rhesus rotavirus (RRV) and generated a panel of hybridoma cell clones secreting IgA class monoclonal antibodies. A total of 12 neutralizing IgA MAbs to VP4 and VP7 proteins were studied for their epitope specificity and topographical relationships by hemagglutination-inhibition assays, neutralization assays, and competitive-binding assays with previously mapped MAbs. In addition, neutralization-escape virus mutants were selected and gene segments for each variant were cloned and sequenced. Two IgA MAbs were found to be directed to the antigenic region A of the VP7 protein at amino acid 94, and 10 MAbs were directed at the VP8 trypsin cleavage fragment of VP4. Five of the VP4-specific MAbs identified the same neutralization epitope on the RRV VP8 protein, not previously associated with RRV neutralization. All neutralization-escape variants selected by this antibody group contained mutations at amino acids 132-135 of VP4. One IgA MAb selected for a mutation at amino acid 190 of VP4, and the corresponding viral mutant failed to agglutinate erythrocytes. This MAb mapped to an epitope recognized by 2 additional IgA MAbs. These results suggest that oral immunization of mice with RRV elicits an IgA immune response which is predominantly directed toward antigenic determinants on the VP8 portion of VP4. As a consequence, the route of immunization may alter immunodominant neutralization responses elicited to rotavirus. ᭧
INTRODUCTION
antigenic neutralization specificity of the VP7 protein.
More recently, the role of the VP4 spike protein in neuRotavirus is a leading cause of acute dehydrating tralization and the existence of multiple antigenic diarrhea particularly among young children in both deforms of VP4 have been presented (Matsui et al., 1989; veloping and industrialized countries (Kapikian and Taniguchi et al., 1989) . This, together with the indepenChanock, 1990). Infection is also widespread among dent segregation of the genes for VP7 and VP4 neutralanimals, representing a threat in husbandry particuization proteins (Gorziglia et al., 1990; Hoshino et al. , larly for cattle and swines (Saif et al., 1994) . The high 1985) , has led to the adoption of a binarian nomenclamorbidity and mortality associated with human rotaviture for defining rotavirus strains using both the G rus infection make it necessary to develop a safe and (VP7) and the P (VP4) specificities (Nagesha and effective vaccine. Since the discovery of rotavirus Holmes, 1991) . many studies have defined the protective role of anti-VP4 is an 85-kDa protein encoded by gene segment bodies against rotavirus infection and the existence of 4 which is present on the virion as spikes extending from neutralization epitopes on both outer capsid proteins, the VP7 matrix of the outer capsid (Prasad et al., 1988) . VP4 and VP7 (Kalica et al., 1981; The VP4 protein is responsible for the hemagglutination 1983a,b; Hoshino et al., 1985; Taniguchi et al., 1985;  property shared by several rotavirus strains (Mackow et Offit and Blavat, 1986a) . VP7 is a 42-kDa glycoprotein al., 1989) . Trypsin treatment of complete viral particles encoded by gene segments 7 -9, and represents the results in cleavage of VP4 into VP8 (28 kDa) and VP5 major outer capsid structural protein and the primary (60 kDa), components which remain associated with the neutralization antigen of the virus (Bastardo et al., virion and are required for the enhancement of rotavirus 1981). Original rotavirus serotypes were based on the infectivity (Estes et al., 1981) . In a recent study, we have shown that neutralizing monoclonal antibodies (MAbs) to the VP8 peptide efficiently prevent binding of rhesus culture (Ruggeri and Greenberg, 1991) . Although this MATERIALS AND METHODS finding suggests that VP8 is responsible for viral attachCells and virus ment to cellular receptors, the amino acids accounting for this function are still unknown.
MA104 cells were grown in Medium 199 supplemented with 7% fetal bovine serum (FBS) at 37Њ in a 5% Most information on the antigenic response to rotavirus is derived from parenterally immunized mice by CO 2 atmosphere. The virus used in all experiments was the rhesus rotavirus strain RRV. Production of virus studying the elicited hyperimmune sera and monoclonal antibodies (IgG, IgM) . Studies of parenterally immunized stocks was carried out in MA104 cell monolayers in 175-cm 2 flasks infected at a m.o.i. of 0.05. Virus was activated mice emphasize the immunogenicity and immunodominance of VP7 neutralization epitopes (Kalica et al., 1981;  with 5 mg/ml trypsin (type IX; Sigma Chemical Co., St. Louis, MO) at 37Њ for 1 hr before infection, and was grown Greenberg et al., 1983a; Gerna et al., 1984; Lazdins et al., 1985; Sabara et al., 1985) . However, increasing evidence in serum-free medium containing 0.5 mg/ml trypsin. When approximately 80% of the cells showed cytopathic effect, suggests that in both natural and experimental infections VP4 may be a more effective antigen than VP7 (Shaw et monolayers were freeze-thawed thrice and fluorocarbon extracted. al., 1987; Svensson et al., 1987; Ward et al., 1993) . Also, rotavirus is targeted to mature cells of the gut mucosa Virus purification during infection and, as a result, immunity is thought to be primarily provided by a secretory IgA antibody re-RRV-infected cell lysates were ultracentrifuged at sponse. For several viruses, resistance to infection 35,000 rpm in a Beckman Ti45 rotor for 2 hr at 4Њ. The seems to correlate with the presence of specific IgA pellet was resuspended in 10 mM Tris, 100 mM NaCl, antibody in mucosal secretions (Mills et al., 1971 ; Liew 2 mM CaCl 2 , pH 7.4 (TNC), and layered onto a 25% et al., 1984) . Renegar and Small (1991) have recently sucrose cushion in TNC. After centrifugation in a Beckdemonstrated that immunity to influenza virus could be man SW 41 at 35,000 rpm for 2 hr at 4Њ, the virus pellet abrogated by intranasal application of anti-IgA antibodies was resuspended in 1 to 2 ml of TNC, and either used but not anti-IgG or -IgM antibodies consistent with IgA directly for immunization of mice or subjected to further being the major mediator of viral neutralization. Secretory purification. In the latter case, the virus suspension IgA is a polymeric immunoglobulin which is actively was made up to 6 ml in TNC containing CsCl at a transported through the mucosal epithelia by a mechaconcentration corresponding to an average density of nism which is not available to monomeric immunoglobu-1.37 g/ml. After centrifugation at 33,000 rpm in an SW lins like IgG (Solari and Kraehenbhul, 1985) . Transport 41 rotor for 20 hr at 12Њ, the bands corresponding to is mediated by the polymeric immunoglobulin receptor both triple-shelled (TLP) and double-shelled (DLP) viral (pIgR) which is largely expressed on the mucous memparticles were diluted with TNC and centrifuged brane epithelial cells. The complex of pIgR and dimeric through a sucrose cushion as described before. PuriIgA (dIgA) is endocytosed and transported through vesicfied TLP and DLP particles were resuspended in 1 ml ular compartments to the apical surface of cells (transcyof TNC and stored at 4Њ before use. tosed), where proteolysis of pIgR results in release of dIgA bound to the ectoplasmic domain of pIgR (known Immunization of mice as secretory component). It has been suggested that Balb/c mice were supplied by Charles River Laboratranscytosed IgA antibodies may interfere with viral replitories. Both adult (6 weeks) female mice and 6-day-old cation by binding to newly synthesized viral proteins pups from rotavirus serum-antibody-negative dams were within infected cells, thus providing a novel mechanism orally primed with 100 ml of a semipurified RRV preparaof mucosal intracellular virus neutralization (Burns et al., tion. After 3 weeks, mice were further fed with RRV in 1996; Kaetzel et al., 1991; Mazanek et al., 1992) .
the presence of 5 to 10 mg of purified cholera toxin (kindly In this study, we have addressed the secretory IgA donated by A. Gallina, Rome) using sodium bicarbonate immune response to oral rotavirus administration. We (6%) to neutralize the acidic pH of the stomach. Approxihave defined the neutralization specificity of IgA class mately 12 days after boosting, serum samples were monoclonal antibodies elicited in response to oral RRV taken from immunized animals and tested for the presimmunization of mice. Our results suggest that oral rotaence of neutralizing (Nt) and hemagglutination-inhibiting virus immunization elicits a strong neutralizing IgA mono-(HI) antibody to RRV. Most mice had an Nt or HI antibody clonal antibody response to immunodominant domains titer ranging from 1:800 to 1:3200 after the second boost. on the VP8 portion of RRV VP4. These results indicate that the route of immunization is a key factor in the evaluFusion ation of mucosal neutralizing antibody responses and that the enhancement of immune responses to secretory
Mice showing a seroconversion to RRV received a final oral boost along with an intravenous injection of IgA-specific neutralization domains needs to be considered in rational vaccine development.
virus 4 days before fusion. Animals were sacrified, and the small bowel, the mesenteric lymph nodes, and the Enzyme-linked immunosorbent assay spleen were resected. Preparation of spleens for fusion For analysis of hybridoma supernatants, microtiter was performed as previously described by Greenberg ELISA plates were incubated overnight with 50 ml/well and co-workers (1983b). The gut was thoroughly of purified DS-RRV diluted 1:100 in PBS, and blocked with washed using sterile medium (DMEM) supplemented either 1% gelatin or 5% FBS in PBS for 1 hr at 37Њ. Wells with 200 mg/ml gentamicin and 5 mg/ml Fungizone, and were incubated with a 1:10 dilution of hybridoma cell the Peyer's patches were dissected with a fine scalpel supernatants in PBS containing 5% bovine serum albuand homogenized with a dounce homogenizer together min (BSA) for 2 hr at 37Њ. After washing, plates were with mesenteric lymph nodes. The resulting cell susincubated with a 1:2000 dilution of an anti-mouse IgA (apension was centrifuged through an FBS cushion at chain) antibody conjugated with alkaline phosphatase 1000 rpm for 8 min in a Beckman T-J6 centrifuge. Lym-(Sigma) for 1 hr at 37Њ. Duplicate plates were examined phocytes were counted using a vital stain, and the confor IgG and IgM MAbs, and secondary incubation was centration of cells was adjusted to about 10 9 /ml. Sepaeffected with a 1:2000 dilution of anti-mouse IgG (H/L) rate fusions were carried out simultaneously for spleen antibody (Sigma). Reaction was then developed with pcells and cells from regional lymphoid tissues, using the nitrophenol phosphate (Sigma 104) in 10 mM diethanosame procedure (Greenberg et al., 1983b) . Hybridoma lamine, pH 10. After 1-hr incubation at 37Њ, optical densisupernatants were screened using an HI assay with ties were measured at a wavelength of 405 nm using a human group O erythrocytes, a focus-reduction microBio-rad ELISA reader. Absorbance values equal to or neutralization test (FRN), and an enzyme-linked immuhigher than fivefold the background were considered to nosorbent assay (ELISA) using purified TLP-RRV as capbe positive. In particular assays, ELISA plates were ture antigen and an alkaline phosphatase-conjugated coated with DLP-RRV or with a 1:100 dilution of baculovianti-mouse IgA (a-chain) or IgG (H/L) secondary antirus-expressed RRV VP8 (Fiore et al., 1991) or VP5(1) (L. body (see below). Selected cultures were cloned by Fiore, unpublished). limiting dilution using a mouse thymocyte feeder layer, and MAbs were amplified in mouse ascites. ConfirmaWestern blotting tion of MAb isotype was performed by ELISA using a Semipurified RRV preparations were subjected to mouse antibody isotyping kit (Pierce, Rockford, IL).
SDS-PAGE under denaturing conditions, and viral protein bands were transferred to nitrocellulose paper using Radioimmunoprecipitation (RIPA) a semidry apparatus (Bio-Rad) according to the manufacturer's instructions. After blocking with 5% skim milk in Preparation of 35 S-labeled RRV-infected MA104 cell PBS for 1 hr at 4Њ, blots were incubated with a 1:100 lysates was performed as previously described dilution of ascites fluids in PBS-1% BSA for 3 hr at 4Њ. (Greenberg et al., 1983b) . A conventional immunoprecipiSecondary incubation was carried out with anti-mouse tation assay using immobilized protein A could not be IgA or IgG or anti-guinea pig IgG antibodies conjugated used because of the lack of reactivity of our IgA MAbs with alkaline phosphatase. After washing, detection of with protein A. Therefore, we have adopted a method bands was performed by incubation with bromochloroinsimilar to that formerly described by Burns and co-workdolyl phosphate/nitroblue tetrazolium in 100 mM Tris, 100 ers (1988) . Wells of a high-binding ELISA plate (ImmunomM NaCl, 5 mM MgCl 2 (pH 9.5). lon 2; Dynatech Laboratories, Inc., Chantilly VA) were antibody coated by overnight incubation at 4Њ with a 1:100
Hemagglutination-inhibition assay dilution of ascites fluid in phosphate-buffered saline HI assay was performed as previously described (Kal-(PBS). After washing with PBS containing 0.5% Tween 20 ica et al., 1983) . Briefly, 25 ml of a 1:10 dilution of hybrid-(PBS/T), the plates were blocked with 1% gelatin (Biooma cell supernatants for screening of fusions or serial Rad Laboratories, Richmond, CA) in PBS for 1 hr at 4Њ. In twofold dilutions of selected MAbs in PBS/0.5% BSA were the case of guinea pig or mouse control sera, to increase mixed with equal volumes of RRV suspension containing antibody binding the wells were precoated with soluble 8 hemagglutinating units in 96-well plates. After 1-hr incuprotein A (10 mg/ml in PBS). Fifty microliters of radiolabation at room temperature, 50 ml of human group O beled lysate were then added to each well, and the plates erythrocytes at the concentration of 0.4% in PBS/BSA were further incubated overnight at 4Њ on an orbital were added to each reaction. HI titers were calculated as shaker. After extensive washing with RIPA buffer (10 mM the reciprocal of the highest antibody dilution preventing Tris-HCl, 100 mM NaCl, 600 mM KCl, 0.2 mM EDTA, 1% hemagglutination. Triton X-100; pH 7.6), wells were incubated with 70 ml of electrophoresis sample buffer (Laemmli, 1970) for 1 min
Epitope competition ELISA on a heated metal block. SDS-polyacrylamide gel electrophoresis (PAGE) and autoradiography were performed This assay was used to determine the ability of the IgA MAbs to compete with IgG MAbs of known epitope as previously described (Greenberg et al., 1983b) . specificity for binding to RRV. TLP-RRV-coated ELISA sence of antibody. Neutralization was considered significant when there was a 60% or greater reduction in plaque plates were incubated with serial twofold dilution (50 ml/ well) of either ascites fluid containing IgA MAbs or purinumber. fied IgG or IgM preparations (Shaw et al., 1986; Mackow Production of RRV antigenic variants et al., 1988a,b) in PBS/BSA for 1 hr at 37Њ. Twenty-five microliters of an appropriate dilution of each challenge Neutralization-resistant RRV variants were selected in IgG and IgM or IgA antibody was then added, and incuba-MA104 cell monolayers by direct plaquing of 10 7 to 10 8 tion was continued for 45 min. After rinsing with PBS/T, PFU of RRV previously neutralized with each single IgA an alkaline phosphatase-conjugated anti-mouse IgG (gMAb and including the antibody in the overlay medium chain), IgM (m-chain), or IgA (a-chain) diluted to 1:2000 during growth, as described in detail by Shaw and cowas added, respectively. Plates were incubated for 1 workers (1986). In some cases, a preliminary amplificahr at 37Њ and washed, and reaction was developed as tion of virus in liquid medium in the presence of antibody described above. Antigen, detecting antibody, and chalwas needed prior to plaquing under an agarose-conlenge antibody concentrations were all adjusted to give taining overlay. Single well-developed viral plaques were an OD 405 of 0.8-1.2 in the absence of competition. After picked from plates, and subjected to at least two further subtraction of background (usually õ0.080 in wells excycles of plaque purification before cell culture expanposed to all reagents except the challenge antibody), sion in antibody-free medium. Identification of neutralizareduction of test OD values higher than 70% compared tion-escape RRV mutants was eventually confirmed by to control wells was considered indicative of a significant neutralization and HI tests. Virus variants were desigcompetition between each pair of antibodies tested.
nated with the same code of the selecting MAb preceded by a ''v''.
Focus reduction neutralization assays
Nucleotide sequencing An immunoperoxidase staining technique for detecting infected cells was used in a microneutralization assay Plus-stranded RNAs of RRV and neutralization-escape as described previously (Shaw et al., 1985 (Shaw et al., , 1986 . Approxmutants were synthesized in vitro using the endogenous imately 200 focus-forming units of RRV were mixed either RNA polymerase activity of DLP particles, as described with a 1:10 dilution of hybridoma cell supernatants for previously (Flores et al., 1982) . After phenol extraction, screening of fusions or with serial dilutions of MAbs, and ssRNA was precipitated with 2 M LiCl in an ice bath the mixtures were incubated for 60 min at 37Њ prior to overnight, resuspended in H 2 O, and further precipitated inoculation onto MA104 cells in 96-well plates. Infected in 70% ethanol in the presence of 0.3 M sodium acetate cells were fixed 18 hr later with cold methanol, and incuat 070Њ. Genes 4 and 9 were sequenced directly from bated with a guinea pig hyperimmune antiserum to RRV mRNA by Sanger's method essentially as previously de-(1:1000) followed by incubation with a peroxidase-conjuscribed (Sanger et al., 1977; Zagursky et al., 1985) , using gated antibody to guinea pig Ig (1:2000) . Staining was avian myeloblastosis virus reverse-transcriptase (Seikeperformed by reaction with aminoethylcarbazole in 50 gaku, Inc.) and a series of negative-strand oligonucleomM acetate buffer, pH 6. Neutralizing titers were extide primers spanning the whole length of either gene at pressed as the inverse dilution resulting in a 60% or intervals of 200 to 250 nucleotides (Mackow et al., higher reduction in the number of infected MA104 cells.
1988a,b). To verify sequence in regions of RNA with a high degree of secondary structure, additional plusPlaque reduction neutralization assay stranded primers were used to sequence cDNA synthesized by reverse transcription of viral mRNAs and PCR Trypsin-activated RRV was diluted with 1% BSA in amplification. Specific DNA regions were sequenced di-M199 to give a concentration of approximately 10 8 PFU/ rectly or following cloning into pCRscript (Stratagene, ml. Aliquots of the viral suspension were then reacted Inc.) with Sequenase 2.0 (U.S. Biochemical Corp., Clevewith each MAb through a wide range of ascites dilutions.
land, Ohio). Neutralization was allowed to take place for 2 hr at 37Њ and overnight at 4Њ; each reaction mixture was then seri-RESULTS ally diluted and plated onto MA104 cells in 6-well plates in duplicate. After 90-min adsorption at room temperaHybridoma screening ture, monolayers were washed three times and overlaid with M199 containing 0.5 mg/ml trypsin and 0.55% aga-A total of 73 hybridoma cell culture supernatants from three separate fusions were found to react with RRV in rose (SeaKem; FMC BioProducts, Rockland, ME). After incubation at 37Њ for 3 days in a CO 2 atmosphere, plaques an ELISA assay specific for murine IgA antibody. Of these, 33 supernatants also showed HI and neutralizing were stained with neutral red and counted. Data were expressed as the percentage of nonneutralized virus activity at the initial screening. Twelve neutralizing and 6 nonneutralizing cultures were randomly chosen for furcompared to control wells infected with virus in the ab- ther study and cloned thrice, and MAbs were amplified Two further neutralizing MAbs (4G12 and 5B9) did not react with VP4 subfragments; however, these antibodies as murine ascites. All MAbs were confirmed to be IgA by an ELISA assay using class-and subclass-specific strongly stained wells coated with TLP-RRV but not DLP-RRV. Although to a lesser extent than TLP-RRV, control antisera to mouse immunoglobulins. Ascites fluids were also analyzed by SDS-PAGE under nonreducing condiIgG MAb 159 also stained DLP-RRV wells, which is probably related to the higher sensitivity of the IgG-ELISA tions, and the gel was blotted onto nitrocellulose paper. In all cases, staining with an alkaline phosphatase-conjuused. As DLPs differ from whole virions in that they lack both outer capsid proteins VP4 and VP7, these findings gated antiserum to mouse IgA revealed the presence of a major protein band migrating with an apparent molecular suggested that MAbs 4G12 and 5B9 might recognize VP7, present as a contaminant in the DLP-RRV gradient weight of 300,000 Da, and less evident bands at 150,000 and 60,000 Da (not shown). This indicates that most antifraction. The remaining 5 nonneutralizing MAbs (1D4, 2C5, 2F7, 2F8, and 3H5) stained both TLP-and DLPbody in our preparations was dimeric.
RRV-coated wells, but gave no reaction with any of the expressed viral proteins.
Determination of the specificity of MAbs for RRV
To confirm antigen specificity of IgA MAbs, ascites proteins fluids were used in a solid-phase immunoprecipitation None of the selected IgA MAbs reacted with RRV protest as capture antibodies for radiolabeled viral proteins teins in Western blots (not shown), suggesting that they from RRV-infected cell lysates. Since our IgAs did not recognize conformation-dependent epitopes. For 11 bind protein A-activated beads, this assay was used as MAbs, identification of the protein specificity could be an alternative method to a conventional RIPA, which uses established by using baculovirus-expressed RRV VP4 immobilized protein A for immune complex capture. Resubfragments VP8 and VP5(1) as capture antigens in an sults of this assay are shown in Fig. 1 . Consistent with ELISA assay ( Tables 3 and  4 . No competition was found between antibodies di-VP4-specific MAbs, including control MAb 1A9 previously mapped in the VP8 subfragment of RRV VP4. This protein rected at different RRV proteins. IgA MAbs 4G12 and 5B9 showed a two-way competition with IgG antibodies 4F8 was found in different preparations of RRV-infected lysates, and probably represents a cytoplasmic proteolysis and 159 which map to the A antigenic region of RRV VP7. To a lesser extent, competition was also found with MAb product of native VP4. Five nonneutralizing IgA MAbs (1D4, 2C5, 2F7, 2F8, and 3H5) selectively precipitated 5H3 that recognizes a distinct epitope of the same protein. Among the VP8-specific IgA MAbs, at least four VP6 from RRV lysates, whereas the two remaining neutralizing MAbs (4G12 and 5B9) did not react with any distinct patterns of competition were observed with control VP8 and VP5 IgG or IgM MAbs. Four IgA MAbs (2A10, RRV peptide. These latter antibodies were established as being directed toward the VP7 protein by a competitive 3F12, 4B7, 4C2) showed no reactivity with any of the control antibodies. IgA MAb 3G6 showed a one-way com-ELISA (see below) and by immunoperoxidase staining of insect Sf-9 cells infected with recombinant baculovirus petition with IgM MAb M14, when the latter was used as competing antibody. A further IgA MAb (5E2) showed expressing RRV VP7 (Table 2) (the procedure was developed by Greenberg and co-workers and will be dea two-way competition with IgG MAb 7A12 and was nonreciprocally competed by MAb M14. A completely distinct scribed in detail elsewhere; H. B. Greenberg et al., manuscript in preparation) . In this assay, a large number of control VP7 neutralizing MAbs were reactive (data not pattern of reactivity was shown by three other VP8-IgA to resist neutralization by the IgA antibodies used for their selection. MAbs (1C4, 1E4, and 4B6) that presented a two-way competition with three IgG antibodies (23, 1A9, 7A12) mapping into a discontinuous major neutralization epitope of Hemagglutination-inhibition analysis of neutralization-VP8. MAb 2B12 behaved slightly differently from the latter escape mutants with MAbs IgA MAbs, in that it did not show competition with IgG MAb 7A12, whereas it competed with IgM MAb M14.
Nine RRV variants, plaque isolated under the selective pressure of distinct IgA neutralizing MAbs, were examNeutralization curves of IgA MAbs ined by a HI test using a wide panel of monoclonal antibodies (Table 5) . Based on the results of assays, four Neutralization curves were obtained for the 12 neuvariants (v2A10, v3G6, v4B7, and v4C2) could be astralizing IgA MAbs by testing a wide range of ascites signed to a same major group of reactivity, all of them fluid dilutions against high titer RRV preparations in a being resistant to any of the corresponding MAbs. plaque inhibition assay. Figure 2 shows typical examples Among them, v4C2 showed only a partial resistance to of the curves obtained. All antibodies directed at VP8 MAb 2A10. All variants included in this group were also caused a reduction of virus infectivity in the order of 100-resistant to MAb 3F12. The viral mutant selected with fold or less in a range of ascites dilutions between 1:3200 this latter antibody (v3F12) proved only resistant to the and 1:32,000; further decrease of antibody dilution did homologous MAb, thus showing a one-way correlation not result in higher rates of neutralization. A stronger with the former group of viruses. Hemagglutination by neutralization activity was shown by the two IgA MAbs mutant v5E2 was also resistant only to the 5E2 MAb. In to the VP7 protein, both of which were able to reduce addition to the MAb used for its selection, the VP8-spevirus titer by about 4 log 10 . Anti-VP8 and -VP7 IgA MAbs cific virus mutant v2B12 also showed lack of reactivity showed neutralization curves similar to those observed with the IgM MAb M14 directed at the VP8 portion of with IgG MAbs of similar protein specificities (Ruggeri VP4 . With this unique exception, all of the above mutants and Greenberg, 1991) . None of the VP6-or VP5-specific were sensitive to all of the VP4 and VP7 reference MAbs IgA MAbs generated in this study had any effect on virus tested. Variants v4G12 and v5B9 showed cross-resisinfectivity in this assay at 1:10 dilutions of ascites.
tance to the corresponding MAbs and to reference MAbs 159 and 4F8, whereas they were sensitive to MAb 5H3.
Isolation of neutralization-escape RRV mutants
Ten virus variants were selected by overlaying RRVNeutralization of viral mutant v4B6 by MAbs infected MA104 cell monolayers with neutralizing IgA Although grown to titers exceeding 5 1 10 7 PFU/ml, MAbs and isolating RRV mutants which escaped IgA the virus variant selected with MAb 4B6 showed no hemMAb neutralization. Despite any efforts, RRV viral variants agglutination property. Therefore, its reactivity with other were not selected when VP8-specific MAbs 1C4 and 1E4
MAbs was examined by a microplate neutralization were included into the infection medium. All of the isoassay (Table 5 ). In addition to the homologous antibody, lated variants could be grown to similar titers as wildv4B6 also fully resisted neutralization by IgA MAbs 1C4, type RRV, following replication on cell cultures, in the 1E4, and 5E2, and by reference MAbs 23, 1A9, and 7A12. presence or absence of the IgA MAbs that selected them.
It also showed a low degree of resistance to all reAll variants except one, v4B6, were also able to agglutimaining MAbs to VP8, but not to antibodies directed at nate human group O erythrocytes. After several passages in MA104 cells, all mutants maintained the ability VP5 or VP7.
FIG. 2. Neutralization of RRV infectivity by
IgA monoclonal antibodies directed at VP4 and VP7. Reference IgG MAb 2G4 (VP5*) is included. Trypsin-treated RRV (10 8 PFU/ml) was mixed with ascites fluids at indicated dilutions, and incubation was done at 37Њ for 2 hr and at 4Њ overnight. Virus-antibody mixtures were diluted and inoculated onto MA104 cell monolayers in 6-well plates in duplicate. At 3 days postinfection, monolayers were stained with neutral red and viral plaques were counted. Data are expressed as percentage of residual infectivity after neutralization compared with virus incubated in the absence of antibody. For details, see Materials and Methods. Dotted line indicates 60% infectivity reduction.
Sequence analysis of neutralization-escape mutants
For a more detailed characterization of the virus variants isolated, the nucleotide sequence of the genomic segment coding for the viral protein recognized by each of the IgA MAbs used for selection was determined. The gene sequences corresponding to each mutant were compared with the sequences of wild-type RRV genes 4 and 9, respectively. The results of comparisons are summarized in Table 6 . In each case, IgA MAb-selected variants contained a single base change which conferred a single amino acid change to the encoded VP4 or VP7 outer capsid protein and permitted the variant to escape neutralization by the IgA MAb. Five of the neutralizationescape mutants (v2A10, v3F12, v3G6, v4B7, v4C2) isolated with the VP7-specific IgA MAbs (4G12, 5B9) showed a mutation of base 328 and 329, respectively, antigens including viruses (Lycke and Holmgren, 1986 ; corresponding to an amino acid change at position 94.
Chen and Strober, 1990), was used in subsequent oral administration of rotavirus. Hence, pups were primed with an initial oral RRV dose which induced diarrhea, and DISCUSSION were boosted orally with a combination of RRV virions A great deal of interest has been centered on defining and cholera toxin in order to induce secondary immune the basis of immunity to rotaviruses due to the worldwide responses. clinical importance of these enteric pathogens. The pres-
The suitability of this immunization protocol appears ence of neutralizing antibody in the intestine has been to be supported by the identification of a high level of correlated with protection against rotavirus disease in neutralizing antibodies to RRV in most murine sera taken several animal model systems (Snodgrass and Well, after a single booster dose of rotavirus. In addition, a 1976; Saif et al., 1983; Offit et al., 1986b; Matsui et al., proportion close to 50% of cell supernatants from primary 1989). Detailed analyses of the antigenic domains in both fusion cultures showed reactivity with RRV antigen in rotavirus neutralization proteins, VP4 and VP7, have been an IgA-specific ELISA, suggesting a specific targeting to conducted with the use of monoclonal antibodies and immune cells involved in secretory antibody response. viral neutralization-escape mutants (Taniguchi et al., In fact, all MAbs tested were mostly produced in the form , 1988a Burns et al., 1988; Shaw et al., 1988 ; Zhou of dimers, and therefore may be suitable for recognition et al., 1994) , and the presence of at least three neutralizaby the poly-Ig receptor that mediates transport of secretion epitopes on VP4 and VP7 has been reported. Neutory antibodies through mucosal epithelia (Kraehenbuhl tralizing antibodies of IgG or IgM immunoglobulin and Neutra, 1992). classes resulting from parenteral immunization of mice Although the MAbs described in this paper represent with rotavirus have been used in these studies. However, only a sample of the cultures obtained, it is of interest that it has been emphasized by several investigators (Dhara-10 of 12 neutralizing antibodies which were randomly kul et Losonsky et al., 1988; Conner et al., 1991;  selected for the study were shown to be directed at VP4. Merchant et al., 1991; Coulson et al., 1992) that these Since VP4 is stoichiometrically underrepresented relative humoral responses are not likely to fully represent the to the VP7 on rotaviruses, this suggests that the VP4 local immune mechanisms which mediate protection in protein may be particularly efficient at eliciting neutralizthe intestinal mucosa.
ing immune responses at the intestinal mucosa (Shaw In this study, we have analyzed the neutralizing secreet al., 1988; Ward et al., 1988 Ward et al., , 1993 and, as opposed to tory IgA response to rotavirus antigens and defined IgAIgG immune response studies, suggests that the VP7 specific neutralization sites in the VP4 and VP7 proteins protein may play a secondary role in mucosally derived of RRV. As in natural infections, we have developed an neutralizing immunity. On the other hand, a possible conoral immunization strategy that made it possible to isotribution of cholera toxin in enhancing the neutralizing late a library of murine IgA monoclonal antibodies to immune response to VP4 more than to VP7 cannot be RRV. First, we have taken advantage of the fact that, ruled out, even though no data are available to sustain although adult Balb/c mice are not susceptible to rotavithe hypothesis of a differential stimulation of antigenic rus disease, diarrhea can be induced in pups up to 2 responses by cholera toxin. Virus-specific IgA antibodies weeks of age by oral administration of live virions (Riehave also been shown to be produced by lamina propria penhoff et al., 1982). Second, cholera toxin, which has lymphocytes as a result of parenteral immunization with been reported to strongly enhance mucosal immune responses to a great variety of soluble and particulated rotavirus (Coffin et al., 1995) . Comparison of the epitope specificity of IgA responses following oral or parenteral Isolation of MAbs to this epitope has been reported for several animal and human strains of rotavirus (Mackow immunization with rotavirus could provide definite information on the importance of the inoculation route in deet al., 1988b; Taniguchi et al., 1988b) , and Shaw and coworkers (1987) have presented evidence of the direct termining the epitope pattern of the immune response.
Characterization of the two VP7-specific IgA monoinvolvement of this epitope in protection among children vaccinated with RRV. Our results may indicate a relatively clonal antibodies which select for variants with mutations at amino acid 94 confirms previous findings of an antilow immunogenicity of the VP5 heterotypic epitope in gut immune responses and its underrepresentation followgenically highly reactive epitope at this position (Dyall et al., 1986; Mackow et al., 1988a; Taniguchi et al., 1988a) .
ing oral immunization. Immune responses to oral immunization identify VP8 Neutralizing antibodies to this domain have been isolated for both animal and human strains of rotavirus, and as the major immunogenic element of both VP4 and RRV. The VP8 peptide has been both shown to carry the role of this epitope in in vivo protection has been clearly demonstrated (Matsui et al., 1989) . Both IgG and the viral hemagglutinin (Fiore et al., 1991) and suggested to play an important role in virus binding to host IgM antibodies directed at this epitope have been shown to exert a strong neutralizing effect on RRV and to act by cells (Ruggeri and Greenberg, 1991) , and therefore it is likely to be highly accessible on the virion surface. single-hit kinetics (Ruggeri and Greenberg, 1991) . Preliminary experiments indicate that the neutralizing IgA MAbs
From competitive binding studies and gene sequence analysis of viral neutralization-escape mutants, our IgA described here are at least as efficient at neutralizing RRV in vitro as previously described IgG and IgM MAbs
MAbs to VP8 are directed toward at least three distinct neutralization epitopes. One of these, recognized by (Ruggeri and Greenberg, 1991) . Some of the MAbs to the aa 94 epitope have been shown to induce heterotypic IgA MAb 2B12, has been previously reported for RRV and mapped at amino acid 148 by a cross-reactive neutralization and protection, whereas most others appear to be G-serotype specific (Dyall et al., 1986; Mackow neutralizing MAb (Mackow et al., 1988b) . A second group of three IgA MAbs (1C4, 1E4, 4B6) showed recipet al., 1988a; Taniguchi et al., 1988a) . Further studies are necessary to verify whether our IgA MAbs are crossrocal binding competition with a series of MAbs previously described to select mutations at amino acid reactive and neutralize G3 serotype rotaviruses other than RRV.
residues 100, 188, and 194 (Mackow et al., 1988b; Zhou et al., 1994) . Of them, only MAb 4B6 was successfully Because of the wide generation of neutralizing antibodies to the aa 94 domain of VP7 obtained by parenteral used to isolate a neutralization-escape mutant (v4B6) which presents a mutation at amino acid 190. It is of immunization, the isolation of orally stimulated IgA MAbs with this antigenic specificity suggests that the aa 94 interest that this virus mutant, although grown to high infectious titers similarly to parental RRV, did not show neutralization site is of particular importance to viral neutralization by all immunization routes. The presentation any ability to agglutinate erythrocytes, resembling the SA-11 neutralization-escape mutant to MAb 23 reof the VP7 antigen in a properly folded conformation has been acknowledged as being critical for inducing VP7-ported by Zhou and colleagues (1994) . The MAb 23 variant was also shown to carry a substitution of amino specific neutralizing immune responses (Andrew et al., 1992; Dormitzer et al., 1994) . In fact, several studies using acid 194 of VP4, suggesting that residues 190 and 194 are critical for HA function. In contrast, mutation identirecombinant VP7 to induce immunity to rotavirus in animals have had limited success (Andrew et al., 1987 (Andrew et al., , 1990  fied at amino acid 188, selected by MAb 7A12 (Mackow et al., 1988b) , does not affect viral hemagglutination. Arias et al., 1986; McCrae and McCorquodale, 1987; McGonigal et al., 1992) . Our data indicate that an immuThese data also suggest that the HA domain and the cell-binding domain on rotavirus may be localized in nologically reactive conformation of the VP7 protein is presented to the mucosal immune system by oral immudifferent sites on VP4, as previously hypothesized (Mendez et al., 1993) . nization.
One major difference noted in the oral immune re-A strict functional correlation between distant portions of the VP8 molecule is suggested by finding that variant sponse to RRV administration is the overwhelming neutralizing IgA response to the VP4 protein, specifically to v4B6 is fully resistant to neutralization by IgG MAbs 23 and 7A12 (selecting amino acid changes at 194 and 188, the 28-kDa amino-terminal trypsin cleavage fragment, VP8. None of the neutralizing antibodies was directed at respectively) and by MAb 1A9, selecting amino acid change at residue 100. Whether this indicates a close the VP5 portion of VP4, which was previously shown to contain an epitope involved in heterotypic neutralization spatial relation between the two epitopes on folded VP4 in the virion or a conformational alteration induced by a and protection (Offit et al., 1986b; Shaw et al., 1986) . The VP5 cross-reactive neutralization epitope maps to the aa change in amino acid at a distant site is not known at present. However, it should be noted that v4B6 also 393 region of VP4 by neutralization-escape mutants and has been illustrated in a cryoelectron microscopy study showed some degree of resistance to neutralization by virtually all the MAbs to VP8 tested suggesting a minor of the VP4 spikes of SA-11 rotavirus (Prasad et al., 1990 In agreement with the epitope competition data, the amino acid changes at residues 132-135 were normally (1996) . Protective effect of rotavirus VP6-specific IgA monoclonal neutralized by the whole panel of reference MAbs to VP4
antibodies that lack neutralizing activity. Science 272, 104-107. and VP7 used in this study. The aa 132-135 mutants Chen, K.-S., and Strober, W. (1990) . Cholera holotoxin and its B subunit were also fully neutralized by all other IgA MAbs belongenhance Peyer's patches B cell responses induced by orally adminising to the groups described above. Altogether, these data tered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol. 20, [433] [434] [435] [436] indicate that the aa 132-135 epitope is completely sepaCoffin, S. E., Klinek, M., and Offit, P. A. (1995) . Induction of virus-specific rated from other known antigenic domains of RRV VP4.
antibody production by lamina propria lymphocytes following intraThe pattern of resistance to MAb neutralization was submuscular inoculation with rotavirus. J. Infect. Dis. 172, [874] [875] [876] [877] [878] stantially similar for four of the five mutants which showed loss of reactivity with only the MAbs belonging Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 65, 2562 Virol. 65, -2571 to the group. Unexpectedly, the fifth virus variant v3F12
Coulson, B. S., Grimwood, K., Hudson, I. L., Barnes, G. L., and Bishop, escaped neutralization by only the homologous IgA MAb. R. F. (1992) . Role of coproantibody in clinical protection of children It is possible that the alanine to valine change at position during reinfection with rotavirus. J. Clin. Microbiol. 30, 1678 -1684 135 selected in variant v3F12 does not significantly alter Dharakul, T., Riepenhoff, T. M., Albini, B., and Ogra, P. L. (1988) . Distrithe reactivity of other MAbs since both residues share bution of rotavirus antigen in intestinal lymphoid tissues: Potential role in development of the mucosal immune response to rotavirus. similar aliphatic side chains, but this change is sufficient Clin. Exp. Immunol. 74, [14] [15] [16] [17] [18] [19] to prevent binding of the selecting MAb. In all other muDormitzer, P. R., Both, G. W., and Greenberg, H. B. (1994) on the virion VP8 protein that may not be a normal com-
